CellSource Co., Ltd. operates within both the regenerative medicine and consumer product sectors. Among its offerings is Signalift, an anti-aging solution. The company, which was established in 2015, is headquartered in Tokyo, Japan.
Latest quote
¥343
−¥3.00 · -0.87%
Regular session · JST · Market data may be delayed.
CellSource Co., Ltd. operates within both the regenerative medicine and consumer product sectors. Among its offerings is Signalift, an anti-aging solution. The company, which was established in 2015, is headquartered in Tokyo, Japan.
Day range
Current ¥343
52-week range
Current ¥343
Regular session · JST · Market data may be delayed.
CellSource Co., Ltd. operates within both the regenerative medicine and consumer product sectors. Among its offerings is Signalift, an anti-aging solution. The company, which was established in 2015, is headquartered in Tokyo, Japan.
Day range
Current ¥343
52-week range
Current ¥343
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.71B JPY | 4.36B JPY | 4.51B JPY | 4.27B JPY | 2.92B JPY |
| Cost of goods sold | 1.62B JPY | 1.99B JPY | 1.35B JPY | 1.22B JPY | 859.61M JPY |
| Gross profit | 2.09B JPY | 2.36B JPY | 3.16B JPY | 3.05B JPY | 2.06B JPY |
| Research and development | 19.07M JPY | 71.01M JPY | 72.45M JPY | 87.56M JPY | 71.16M JPY |
| Selling, general, and administrative | 1.9B JPY | 2.16B JPY | 1.87B JPY | 1.39B JPY | 998.22M JPY |
| Operating expenses | 1.92B JPY | 2.23B JPY | 1.94B JPY | 1.48B JPY | 1.07B JPY |
| Interest income | 251K JPY | 48K JPY | 13K JPY | 7K JPY | 2K JPY |
| Interest expense | 1.31M JPY | 1.36M JPY | 379K JPY | 11K JPY | 136K JPY |
| Depreciation and amortization | 204.32M JPY | 153.23M JPY | 66.38M JPY | 61.15M JPY | 54.26M JPY |
| Operating income | 166.71M JPY | 129.16M JPY | 1.22B JPY | 1.57B JPY | 993.25M JPY |
| Net income | 10.66M JPY | 237.94M JPY | 923.14M JPY | 1.02B JPY | 651.4M JPY |
Company facts updated Sep 7, 2026.
Recent quarterly results
Recent quarterly results
Cash distributions grouped by calendar year; partial years are marked.
¥5.00
2025 complete year-75.0% since 2023
¥20.00
2,023
¥5.00
2,024
¥5.00
2,025
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Oct 30, 2025 | ¥5.00Annual | Oct 31, 2025 | Jan 13, 2026 |
Dividend | Oct 30, 2024 | ¥5.00Annual | Oct 31, 2024 | Jan 14, 2025 |
Dividend | Oct 30, 2023 | ¥20.00Annual | Oct 31, 2023 | Jan 9, 2024 |
Ex-dividend Oct 30, 2025
¥5.00
Annual
Record Oct 31, 2025 · Payment Jan 13, 2026
Ex-dividend Oct 30, 2024
¥5.00
Annual
Record Oct 31, 2024 · Payment Jan 14, 2025
Ex-dividend Oct 30, 2023
¥20.00
Annual
Record Oct 31, 2023 · Payment Jan 9, 2024
Funds reporting this stock among their holdings, ordered by reported position size.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.